High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
Kavya Pathak, Claire Narang, Thomas J. Hwang, Juan Espinoza, Florence T. Bourgeois
Abstract
This cohort study examines the characteristics of high-risk therapeutic devices approved by the US Food and Drug Administration for use in children and adolescents between 2016 and 2021.
Topics & Concepts
MedicineFood and drug administrationDrugAdministration (probate law)Off-label useDrug administrationCohortCohort studyFamily medicineIntensive care medicinePediatricsEnvironmental healthPsychiatryPharmacologyInternal medicinePolitical scienceLawPharmaceutical studies and practicesEthics and Legal Issues in Pediatric HealthcareHealth Systems, Economic Evaluations, Quality of Life